141 related articles for article (PubMed ID: 7805646)
1. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies.
Cockerell OC; Hart YM; Sander JW; Shorvon SD
Epilepsy Res; 1994 Jul; 18(3):249-60. PubMed ID: 7805646
[TBL] [Abstract][Full Text] [Related]
2. [Costs of drug treatment of neurologic diseases: Parkinson disease, dystonia, epilepsy].
Dodel RC; Pepperl S; Köhne-Volland R; Szucs T; Werhahn KJ; Noachtar S; Oertel WH
Med Klin (Munich); 1996 Jul; 91(7):479-85. PubMed ID: 8756119
[TBL] [Abstract][Full Text] [Related]
3. Cost of schizophrenia to UK Society. An incidence-based cost-of-illness model for the first 5 years following diagnosis.
Guest JF; Cookson RF
Pharmacoeconomics; 1999 Jun; 15(6):597-610. PubMed ID: 10538332
[TBL] [Abstract][Full Text] [Related]
4. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
[TBL] [Abstract][Full Text] [Related]
5. Neurologist adherence to clinical practice guidelines and costs in patients with newly diagnosed and chronic epilepsy in Germany.
Strzelczyk A; Bergmann A; Biermann V; Braune S; Dieterle L; Forth B; Kortland LM; Lang M; Peckmann T; Schöffski O; Sigel KO; Rosenow F
Epilepsy Behav; 2016 Nov; 64(Pt A):75-82. PubMed ID: 27732920
[TBL] [Abstract][Full Text] [Related]
6. Annual cost of bipolar disorder to UK society.
Das Gupta R; Guest JF
Br J Psychiatry; 2002 Mar; 180():227-33. PubMed ID: 11872515
[TBL] [Abstract][Full Text] [Related]
7. The economic consequences of prostate and bladder cancer in the UK.
Sangar VK; Ragavan N; Matanhelia SS; Watson MW; Blades RA
BJU Int; 2005 Jan; 95(1):59-63. PubMed ID: 15638895
[TBL] [Abstract][Full Text] [Related]
8. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data.
Begley CE; Famulari M; Annegers JF; Lairson DR; Reynolds TF; Coan S; Dubinsky S; Newmark ME; Leibson C; So EL; Rocca WA
Epilepsia; 2000 Mar; 41(3):342-51. PubMed ID: 10714408
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study.
Nsengiyumva G; Druet-Cabanac M; Nzisabira L; Preux PM; Vergnenègre A
Epilepsia; 2004 Jun; 45(6):673-7. PubMed ID: 15144433
[TBL] [Abstract][Full Text] [Related]
10. The cost of epilepsy in patients attending a specialist epilepsy service.
Swingler RJ; Davidson DL; Roberts RC; Moulding F
Seizure; 1994 Jun; 3(2):115-20. PubMed ID: 8081637
[TBL] [Abstract][Full Text] [Related]
11. The direct medical costs of epilepsy in children and young people: a population-based study of health resource utilisation.
Ali MA; Elliott RA; Tata LJ
Epilepsy Res; 2014 Mar; 108(3):576-86. PubMed ID: 24447611
[TBL] [Abstract][Full Text] [Related]
12. Estimating the cost of epilepsy in Europe: a review with economic modeling.
Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
[TBL] [Abstract][Full Text] [Related]
13. Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study.
Borghs S; Thieffry S; Noack-Rink M; Dedeken P; Hong LS; Byram L; Logan J; Chan J; Kiri V
BMC Neurol; 2017 Mar; 17(1):59. PubMed ID: 28335764
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of costs of epilepsy using an electronic practice management software in Germany.
Noda AH; Hermsen A; Berkenfeld R; Dennig D; Endrass G; Kaltofen J; Safavi A; Wiehler S; Carl G; Meier U; Elger CE; Menzler K; Knake S; Rosenow F; Strzelczyk A
Seizure; 2015 Mar; 26():49-55. PubMed ID: 25799902
[TBL] [Abstract][Full Text] [Related]
15. An economic analysis of specialist heart failure nurse management in the UK; can we afford not to implement it?
Stewart S; Blue L; Walker A; Morrison C; McMurray JJ
Eur Heart J; 2002 Sep; 23(17):1369-78. PubMed ID: 12191748
[TBL] [Abstract][Full Text] [Related]
16. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview.
Willems LM; Richter S; Watermann N; Bauer S; Klein KM; Reese JP; Schöffski O; Hamer HM; Knake S; Rosenow F; Strzelczyk A
Epilepsy Behav; 2018 Jun; 83():28-35. PubMed ID: 29649671
[TBL] [Abstract][Full Text] [Related]
17. Methodological issues in estimating the cost of epilepsy.
Begley CE; Annegers JF; Lairson DR; Reynolds TF
Epilepsy Res; 1999 Jan; 33(1):39-55. PubMed ID: 10022365
[TBL] [Abstract][Full Text] [Related]
18. Cost of illness of epilepsy in the US: comparison of patient-based and population-based estimates.
Halpern M; Rentz A; Murray M
Neuroepidemiology; 2000; 19(2):87-99. PubMed ID: 10686533
[TBL] [Abstract][Full Text] [Related]
19. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
[TBL] [Abstract][Full Text] [Related]
20. The costs of epilepsy misdiagnosis in England and Wales.
Juarez-Garcia A; Stokes T; Shaw B; Camosso-Stefinovic J; Baker R
Seizure; 2006 Dec; 15(8):598-605. PubMed ID: 17011217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
